Drug interactions
Brexucabtagene autoleucel + Oxaliplatin
Severity: Moderate
Brexucabtagene autoleucel and Oxaliplatin: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Oxaliplatin causes myelosuppression and immunosuppression that may impair the expansion and function of CAR-T cells. Together they may also raise the risk of infections and prolonged cytopenias.
What this interaction means in plain words
Brexucabtagene autoleucel and Oxaliplatin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Brexucabtagene autoleucel belongs to Oncology; Oxaliplatin belongs to Oncology.
Why it happens
Cytotoxic chemotherapy may reduce CAR-T cell expansion and persistence and adds to myelosuppression and immune suppression.
What to do
Avoid giving oxaliplatin in the period around leukapheresis and CAR-T infusion unless required for lymphodepletion or disease control. Monitor blood counts and infections closely if the combination is unavoidable.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Brexucabtagene autoleucel and Oxaliplatin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Oxaliplatin
- Adenovirus types 4 and 7 live + Oxaliplatin Contraindicated
- Bcg vaccine live + Oxaliplatin Contraindicated
- Influenza virus vaccine quadrivalent intranasal + Oxaliplatin Contraindicated
- Measles mumps and rubella vaccine live + Oxaliplatin Contraindicated
- Measles mumps and rubella vaccine + Oxaliplatin Contraindicated
- Measles mumps rubella and varicella vaccine live + Oxaliplatin Contraindicated
Other interactions of Brexucabtagene autoleucel
Frequently asked questions
Can I take Brexucabtagene autoleucel with Oxaliplatin?
MediHelp rates the interaction as moderate. Brexucabtagene autoleucel and Oxaliplatin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Oxaliplatin causes myelosuppression and immunosuppression that may impair the expansion and function of CAR-T cells. Together they may also raise the risk of infections and prolonged cytopenias.
How serious is the interaction between Brexucabtagene autoleucel and Oxaliplatin?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid giving oxaliplatin in the period around leukapheresis and CAR-T infusion unless required for lymphodepletion or disease control. Monitor blood counts and infections closely if the combination is unavoidable.
What other medicines interact with Oxaliplatin?
MediHelp also lists interactions of Oxaliplatin with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Oxaliplatin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
